Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671381 · ClinicalTrials.gov registry record · NA
Improving Access and Affordability of Adult Hearing Healthcare
A NA study of Hearing Loss, sponsored by University of Alabama, Tuscaloo.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT04671381: Recruiting NA study of Hearing Loss, sponsored by University of Alabama, Tuscaloo.
NCT04671381 is a NA study of Hearing Loss that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 210 participants, below the 6,117-participant average among 58 other Hearing Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04671381, a NA study of Hearing Loss, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving over-the-counter hearing aids, it will lead to options that will increase access and affordability of hearing healthcare for adults with mild-to-moderate hearing loss.
Primary Outcome
Twenty-five questions of the Hearing Handicap Inventory for Elderly (HHIE) measure emotional and social/situational consequences of hearing loss, including feelings of embarrassment, social isolation, and frustration. Scores range from 0 to 100 with higher scores indicative of poorer performance.
Conditions Studied
Interventions
- BEHAVIORAL Hearing Evaluation
- DEVICE Over-the-Counter Hearing Aid (OTC HA) Fitting and Orientation
- BEHAVIORAL Four Weeks of Aural Rehabilitation
- DEVICE Provision of Over-the-Counter Hearing Aids
Study Locations (1)
Alabama
- The University of Alabama - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT04671381 shows while recruiting
NCT04671381 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 6,117-participant average among 58 other Hearing Loss trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 4 interventions - of which Hearing Evaluation is the first listed.
NCT04671381 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04671381 about?
NCT04671381 is a clinical study titled "Improving Access and Affordability of Adult Hearing Healthcare". This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving over-the-counter hearing aids, it will lead to options that will inc...
What is the current status of trial NCT04671381?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2021-01-01. Estimated completion is 2025-12.
What conditions does trial NCT04671381 study?
This clinical trial studies the following conditions: Hearing Loss.
What interventions are being tested in trial NCT04671381?
The interventions under investigation include: Hearing Evaluation (BEHAVIORAL), Over-the-Counter Hearing Aid (OTC HA) Fitting and Orientation (DEVICE), Four Weeks of Aural Rehabilitation (BEHAVIORAL), Provision of Over-the-Counter Hearing Aids (DEVICE).
Who is sponsoring clinical trial NCT04671381?
This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04671381 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04671381's enrollment target sits among peer trials
210 25th of 58 higher than 34 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI